Udder Health Market

Udder Health Market Size, Share & Trends

The size of global udder health market in terms of revenue was estimated to be worth $1.2 billion in 2024 and is poised to reach $1.6 billion by 2029, growing at a CAGR of 5.9% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

The growth in the udder health market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising number of veterinarians in the developing countries. At the same time, lack of awareness and education among small-scale dairy farmers can restrain the growth of this market during the forecast period.

Udder Health Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

Udder Health Market Dynamics

DRIVER: Increasing incidence of bovine mastitis and other udder health disorders

The udder health market is experiencing significant growth due to the increasing prevalence of bovine mastitis and other udder health disorders in dairy cattle. Mastitis, an inflammation of udder tissue, is a costly disease affecting dairy cattle globally, leading to billions of dollars in annual losses from reduced milk production, treatment expenses, and decreased milk quality. In the United States alone, mastitis results in over $2 billion in economic losses annually. Studies have shown that in 2021, 40.3% of cows had mastitis, with 11.99% experiencing clinical mastitis and 28.34% subclinical mastitis, while a 2020 study reported that 62.6% of cows had mastitis, with 59.2% subclinical and 3.4% clinical. The disease's costs include reduced milk production, antibiotic residue condemnation, veterinary expenses, and the culling of chronically infected cows.

The rise in mastitis cases highlights the urgent need for effective udder health management solutions, driving demand for advanced diagnostics, innovative treatments, and preventative measures. Dairy farmers are increasingly investing in technologies like automated mastitis detection systems to identify early infection signs and minimize production losses. Growing awareness of the importance of udder health for herd well-being and productivity is fueling market growth. Proactive measures such as proper milking hygiene, optimized herd management, and alternative therapies to reduce antibiotic reliance are becoming popular, aligning with consumer preferences for sustainable and ethically produced dairy products.

RESTRAINT: lack of awareness and education among small-scale dairy farmers

The lack of awareness and education among small-scale dairy farmers significantly hinders the growth of the Udder Health Market. In developing countries like India, Kenya, and Bangladesh, many small-scale farmers lack access to essential resources and information for effective udder health management. A study in Uganda revealed that many small-scale farmers were unaware of mastitis risk factors and preventative measures, contributing to high rates of udder health disorders such as mastitis, reduced milk production, poor milk quality, and increased economic losses.

Efforts to address this issue include education and training programs tailored to small-scale farmers. Organizations, NGOs, and government agencies have implemented outreach programs, workshops, and training sessions to improve awareness and knowledge of udder health practices. Despite these initiatives, more comprehensive and sustained efforts are needed to ensure widespread adoption of best practices, facilitating growth in the Udder Health Market among small-scale dairy farmers globally.

OPPORTUNITY: Increasing per capita income of farmers in developing countries

The rising per capita income among farmers in developing countries presents a significant opportunity for the udder health market. In countries like India and China, increasing incomes are leading farmers to invest more in modern farming techniques and animal welfare, including health management. India, for example, saw a notable 17.4% increase in rural per capita income from 2015 to 2020, reflecting a growing ability and willingness among farmers to spend on improving agricultural practices. Similarly, rural incomes in China have been rising, indicating greater purchasing power and a shift towards higher quality farming inputs.

Governments in developing nations are also supporting this trend through subsidies and incentives aimed at boosting agricultural productivity. Policies in countries like Brazil and Indonesia are designed to enhance rural incomes and agricultural output, creating a favorable environment for the udder health market's expansion. As farmers continue to see their incomes rise, the demand for udder health products such as antibiotics, hygiene solutions, and diagnostic tools is expected to increase, driving further growth and innovation in the sector.

CHALLENGE: Regulatory Control on Livestock Industry to reduce

Regulatory authorities like the USDA, US FDA, Canadian Food Agency, European Medical Agency, MAFF, and APVMA enforce strict guidelines for approving udder hygiene and health products in the livestock industry. These regulations ensure the safety, efficacy, and quality of veterinary pharmaceuticals, including antimicrobials, antibiotics, vaccines, and hygiene products. The Veterinary International Committee for Harmonization (VICH) further harmonizes standards across the US, Europe, and Japan to streamline product registration requirements. Developing and gaining approval for new veterinary pharmaceuticals can be lengthy and costly, with timelines ranging from 5 to 11 years and costs up to USD 75-100 million from development to market. These stringent regulatory processes pose challenges for market players, often discouraging investment in new product development, particularly in areas such as pain management for livestock.

Udder Health Market Ecosystem

In this report, the udder health market is segmented on the basis of product, veterinary care setting, animal type, disease type and region.

Pharmaceuticals segment has accounted for the largest market share in the udder health industry, by product.

Based on the product type, the pharmaceuticals segment holds the largest market share in the udder health market due to several driving factors. Key contributors to this growth include the rising prevalence of udder infections in dairy animals, increasing awareness among farmers about the importance of udder health, and advancements in veterinary medicines. Additionally, the growing demand for high-quality dairy products necessitates effective treatments to maintain udder health, further boosting the use of pharmaceuticals. These medications play a crucial role in preventing and treating infections, ensuring the well-being of dairy animals and enhancing milk production quality and quantity.

By veterinary care setting, veterinary hospitals and clinics segment has accounted for the second largest market share in the udder health industry.

In the field of veterinary care, veterinary hospitals and clinics have captured the second-largest share in the udder health market. This growth is primarily driven by a rising number of veterinarians in developed countries. These professionals play a crucial role in managing and treating udder-related issues in livestock. Their expertise and accessibility in clinics and hospitals have contributed significantly to addressing and preventing health concerns in animals, thereby expanding their market influence within the udder health sector.

Other animals segment has accounted for the second largest market share in the udder health industry, by animal type.

In the udder health market, the other animal segment, which includes goats and sheep, has become the second-largest due to shifting consumer preferences for milk and milk products. More people are choosing goat and sheep milk for its unique taste and nutritional benefits, which has boosted demand. This trend reflects changing customer preferences towards alternative dairy products beyond cow milk, influencing the market dynamics and emphasizing the importance of maintaining udder health in these animals to ensure quality products.

By disease type, Other disease type segment witnessed the largest share in the udder health industry

In the udder health market, the segment related to other types of diseases experienced the highest market share. This is mainly because there has been a notable increase in the number of cows affected by subclinical and chronic mastitis. These conditions, where the udder becomes inflamed or infected, can be difficult to detect early without proper monitoring. As more farmers and veterinarians become aware of these issues, there's a growing demand for products and services that can effectively manage and treat such diseases, driving rapid growth in this particular market segment.

Europe accounted for the largest market share in the udder health industry, by region.

In the Europe region, the udder health market has grown significantly. This is mainly because of advancements in technology that have improved howudder health is managed in dairy cattle. Governments in these countries have also been increasingly supportive, providing assistance and policies to help maintain the health of udders in dairy cows. These factors combined have made Europe the largest market for udder health products and services. As the dairy industry continues to expand in this region, the focus on maintaining the health of cows' udders is becoming even more crucial for sustainable and profitable dairy production.

To know about the assumptions considered for the study, download the pdf brochure

Key players in the Udder health Market: Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan).

Scope of the Udder Health Industry

The research report categorizes the udder health market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Devices
• Pharmaceuticals
• Supplements

By Veterinary Care Setting

• Dairy Farms
• Veterinary Hospitals & Clinics

By Animal Type

• Dairy Cattle
• Other Animals(Goat, Sheep, etc)

By Disease Type

• Clinical Mastitis
• Other Disease Types (Subclinical & Chronic)

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Switzerland
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLA)
• Middle East & Africa
  • GCC Countries
  • Rest of Middle East and Africa

Recent Developments of Udder Health Industry:

• In August 2023, Zoetis Inc. announced the product launch of Vetscan Mastigram+ which is a rapid on-farm mastitis diagnostic, in several markets across Europe.
• In February 2020, Ecolab Inc. introduced Eco-Flex Teat Dip, an effective and affordable udder care solution for dairy cows that helps prevent infection, improve teat health, and support milk quality.
• In February 2022, Orffa announced a distribution agreement with Eigenmann & Veronelli, a leading solution provider in the specialty chemicals and food ingredients Industry in Italy. This acquisition helped the company to promote the ORFFA’s ESSENTIALS product line across Italy.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst